Overview

An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses

Status:
Completed
Trial end date:
2018-11-14
Target enrollment:
Participant gender:
Summary
This study is an open-label study designed to evaluate subject's satisfaction after treatment of seborrheic keratoses with A-101 40%.
Phase:
Phase 4
Details
Lead Sponsor:
Aclaris Therapeutics, Inc.
Treatments:
Pharmaceutical Solutions